Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Careggi University Hospital

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Careggi University Hospital (Azienda Ospedaliero-Universitaria Careggi), located at Largo Giovanni Alessandro Brambilla, 3, 50134 Firenze, Italy, is the largest public polyclinic and teaching hospital in Florence and a primary medical hub for the Tuscany region. Spread across a massive 78-hectare campus at the foot of the Careggi hill, this highly ranked institution serves as a major center for advanced healthcare, cutting-edge medical research, and professional training in close partnership with the University of Florence.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Otolaryngologist
Source: Trial-derived.
120Total Trials
Source: Trial-derived.
35Recruiting Trials
Source: Trial-derived.
64Active Trials
Source: Trial-derived.
38Completed Trials
Source: Trial-derived.
203Unique Conditions
Source: Trial-derived.
131Unique Sponsors

Conditions

Source: Trial-derived. Acute Myeloid Leukemia (4)Source: Trial-derived. Polycythemia Vera (3)Source: Trial-derived. Atrial Fibrillation (2)Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (2)Source: Trial-derived. Covid19 (2)Source: Trial-derived. Crohn's Disease (2)Source: Trial-derived. Cutaneous T Cell Lymphoma (2)

Sponsors

Source: Trial-derived. Fondazione Italiana Linfomi - ETS (14)Source: Trial-derived. Azienda Ospedaliero-Universitaria Careggi (9)Source: Trial-derived. Gruppo Italiano Malattie EMatologiche dell'Adulto (7)Source: Trial-derived. Merck Sharp & Dohme LLC (6)Source: Trial-derived. University of Florence (6)Source: Trial-derived. FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS (4)Source: Trial-derived. Gilead Sciences (3)Source: Trial-derived. Hoffmann-La Roche (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Intravitreal injection

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. 72-hour quantitative stool collection and fecal fat/nitrogen analysis
Source: AI-inferred. Allogeneic haematopoietic cell transplantation programme
Source: AI-inferred. CALR mutation detection and variant allele frequency quantification
Source: AI-inferred. Circulating tumour cell enumeration
Source: AI-inferred. Controlled standardized diet provision (metabolic kitchen)
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Cytogenetic karyotyping